(1)
Bertolani, A.; Ravasio, R.; Raimondo, P.; Jommi, C. The Costs Incurred by Patients to Get Eligibility to PCSK9 Treatment and One-Year Follow-Up: The Results of the PRIOR Study. Grhta 2022, 9, 73-81.